ginsenoside rh2 has been researched along with thiazolyl blue in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (thiazolyl blue) | Trials (thiazolyl blue) | Recent Studies (post-2010) (thiazolyl blue) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 4,625 | 20 | 1,230 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HE; Lee, SK; Oh, JH; Oh, YJ | 1 |
1 other study(ies) available for ginsenoside rh2 and thiazolyl blue
| Article | Year |
|---|---|
Ginsenoside RH-2 induces apoptotic cell death in rat C6 glioma via a reactive oxygen- and caspase-dependent but Bcl-X(L)-independent pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Caspases; DNA Fragmentation; Enzyme Activation; Ginsenosides; Glioma; Immunoblotting; Oxidative Stress; Panax; Plants, Medicinal; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Saponins; Tetrazolium Salts; Thiazoles; Transfection; Tumor Cells, Cultured | 1999 |